All News

This month's product news includes women's wellness supplements, menstrual pain relief cream, and mineral sunscreen.

Study results show a compound annual growth rate of 5.2% from $392.4 billion in revenue in 2021.

The U.S. Health System can be difficult to navigate and creates barriers, which is why speaking up as health care professionals is extremely important.

Each year, the NCPA Annual Convention is able to showcase student business plans in a competition that correlates to a real life business plan.

Ganciclovir injection is a nucleoside analogue cytomegalovirus DNA polymerase inhibitor.

Uric Acid Cleanse helps to managing uric acid levels for kidney support.

Zynteglo was approved for the treatment of adult and pediatric patients with beta-thalassemia who require regular red blood cell transfusions after safety and efficacy were demonstrated in clinical trials.

As local drug delivery technology evolves, the field is set for monumental change.

FDA approved dexamethasone tablets USP 1.5mg, 4mg and 6mg, providing a new generic alternative to the steroid Decadron.

Does your pharmacy have the right technology in place to meet the ever-changing needs of your community and your business?

Rajul A. Patel, PharmD, PhD, director of the Medicare Part D Outreach Clinics at the University of the Pacific in Stockton, California, discusses his work providing drug savings advice to Medicare beneficiaries in diverse communities.

Investigators from University of Texas Health Science Center at Houston analyze data from individuals aged 5 to 18 years enrolled in the Texas CARES survey.

The meta-analysis reviews 38 available studies on the effects of cognitive, physical, and social activities on brain function.

Gilead Sciences Inc submitted a supplemental Biologics License Application to the FDA for sacituzumab govitecan-hziy (Trodelvy) following promising trial results.

Analysis looks at those with arthritis, chronic pain, headaches, lower back pain, and neuropathic pain between 2012 and 2019.

Advise restriction of the nutrient, along with intensive BP control, regimens promoting adherence, use of chlorthalidone in CKD.

Scientists found that inhibiting certain immune system receptors could treat colon cancer and other diseases of the gastrointestinal tract.

The Oncomine Dx Target Test is a next-generation sequencing–based companion diagnostic developed to analyze 23 genes associated with non–small cell lung cancer in patients who harbor an activating HER2 mutation.

Pharmacy managers manage the implementation of services, including ones commensurate with everyday practice as well as newer, more patient-centered services.

A new study found that reduced tobacco use lowered deaths, person-years of lost life, and lost earnings across many states nationwide.

On the first episode, Jeremy Sasser and Jessica Langley-Loep, from the National Healthcareer Association, discuss pharmacy technician's perceptions of patients who may have opioid use disorder.

Zoledronic acid (Zometa) is indicated for the treatment of hypercalcemia that may occur with cancer.

Go-Out is a natural supplement that treats high uric acid levels.

The FDA has issued a rule that will grant millions of Americans access to OTC hearing aids in pharmacies or online without a prescription or medical exam required.

Researchers discovered that a common anti-inflammatory drug could lower the number of patients on ventilators from COVID-19, increasing the likelihood of survival by more than 50%.

High rates of HIV can decrease with community-based support.

Both ibrutinib (Imbruvica) and venetoclax (Venclexta) carry an approved indication for use in chronic lymphocytic leukemia but do not often lead to complete remission, and therapy routinely continues indefinitely or until disease progression.

Pharmacies can play a key role in supporting patients with opioid use disorder and helping diminish stigma for patients treated with methadone, who are told by some they are still addicts despite trying to receive help.

With costs for blood and blood products continuing to rise, appropriate blood use by hospitals is more important than ever.

A new study warns that fluoroquinolone could increase the risk of altered mental status and hospitalizations for advanced chronic kidney disease patients, though it is rare.